Hosted by i3 Health · 🇺🇸 US · EN · 439 episodes
Established thought leaders with verified media credentials.
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
i3 Health hosts Oncology Data Advisor, a science show with 439 episodes published.
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for eac
View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncology care. For clinicians, they represent the ideal environment: multiple special
Check out the full article at: https://oncdata.com/oncology-unfiltered-the-real-world-vs-the-trial-patient Every oncologist knows the moment well: you're reviewing treatment options with a patient, guidelines in hand, wh
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical imp
Think PFIC is only a pediatric disease? Think again. Progressive Familial Intrahepatic Cholestasis (PFIC) was long considered a condition exclusive to children. However, breakthroughs in genomic sequencing are revealing
Melanoma treatment is changing rapidly, with immunotherapy and targeted therapies improving outcomes across multiple care settings. In this expiring CME podcast, Michael A. Davies, MD, PhD, University of Texas, MD Anders
Melanoma care is evolving fast—and staying current can directly impact patient outcomes. In this expiring CME podcast, Michael A. Davies, MD, PhD, The University of Texas, MD Anderson Cancer Center, breaks down how today
Read the full article at: https://oncdata.com/exploring-ai-helioliver Patients diagnosed with early-stage liver cancer have a significantly higher survival rate compared to those diagnosed in later stages, yet screening
The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses how perioperative chemoimmunotherapy and precision biomarkers are redefining the s
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3health.com/course-information/nsclc-advances The FDA’s recent expanded approval
Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment? by i3 Health
Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, a
Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest breakthroughs in research and clinical trials. From navigating
Read the full article at: https://oncdata.com/inav-daniel-king Pancreatic cancer remains one of oncology’s most challenging diseases—fast-moving, hard to detect early, and often diagnosed after curative options have narr
Treatment for systemic mastocytosis (SM) has evolved fast—are your management strategies keeping up? Join Dr. Castells as she dives into the latest advances in SM therapy, including how and when to leverage tyrosine kina
Systemic mastocytosis (SM) can hide in plain sight—are you catching it when it counts? In this case‑driven conversation, Dr. Mariana Castells breaks down the real-world diagnostic journey of SM, highlighting the subtle c
Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of California, San Francisco
Read the full article on Oncology Data Advisor: https://oncdata.com/oncology-unfiltered-molecular-testing In the rapidly evolving landscape of modern oncology, molecular testing has emerged as one of the most powerful to
Read the full article on Oncology Data Advisor: https://oncdata.com/oncology-unfiltered-financial-toxicity In this episode of Oncology Unfiltered, Melissa Cutrona, Co-Founder and General Manager of i3 Health and Oncology
Psoriatic arthritis management is evolving fast, but bridging the gap between clinical evidence and patient experience remains the ultimate challenge. When multidisciplinary teams and patients truly sync, care transforms
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Oncology Data Advisor has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Oncology Data Advisor is hosted by i3 Health. The show is categorised under science and has published 439 episodes.
Oncology Data Advisor has published 439 episodes.
Oncology Data Advisor regularly covers science. It sits in the science category.
Oncology Data Advisor is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Oncology Data Advisor hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Oncology Data Advisor average 18 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Oncology Data Advisor's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.
